PubMed · 1980 · 12 citations · 0 references
Life SciencesBiochemistryCellular MetabolismLipid BiochemistryMetabolismCarbohydrate MetabolismHepatic MetabolismHepatic PathophysiologyLipid MetabolismLiver DiseaseEnzymesFatty AcidsFlightHepatic Enzyme AlterationsHepatic Lipid MetabolismHepatic Microsomal MetabolismHepatic Triglyceride MetabolismLipid Metabolism In Flight
Publisher Summary After the 936 space mission, specific alterations in hepatic enzyme—diglyceride acyl transferase, palmitoyl-CoA desaturase, and glycogen phosphorylase—activities, changes in liver glycogen, and the levels of specific fatty acids were noted in flight animals but not in comparable animals subjected to continuous iodixanol gradient (IG) centrifugation during the mission. The Cosmos 1129 study was designed to reinvestigate some of the 936 observations and to extend the range of inquiry to include hepatic microsomal, mitochondrial enzymes, and other liver constituents, such as triglycerides, phospholipids, and sterols, that were not included in the Cosmos 936 protocol. This chapter discusses a study in which 25 rats were caged individually within a spacecraft; it presents a list of the liver constituents and enzyme activities that were examined in the study and indicate as to which of these were significantly affected by the 18.5 days flight. From the study, it appears that the activities of most of the enzymes and the liver constituents were unaffected by the weightless condition, confirming the observations in the Cosmos 936.